Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Genes and Immunity|May 23, 2003
Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infectionsI A Yang, S L Seeney, J M Wolter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapyS Park, M-H Lee, M Seong, et al.
Bone Marrow Transplantation|April 10, 2007
New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survivalS T Kim, C W Jung, J Lee, et al.
Translational Psychiatry|June 9, 2016
Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorderW Myung, C E Han, M Fava, et al.
Cell Death & Disease|April 13, 2013
Menin mediates epigenetic regulation via histone H3 lysine 9 methylationY-J Yang, T-Y Song, J Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 29, 2016
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibitionS T Kim, S Y Kim, S J Klempner, et al.
European Journal of Neurology|October 31, 2017
Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairmentJ Lee, S W Seo, J-J Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2019
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trialS T Kim, J H Kang, J Lee, et al.
European Journal of Neurology|August 13, 2015
Impact of smoking on neurodegeneration and cerebrovascular disease markers in cognitively normal menH Cho, C Kim, H J Kim, et al.
British Journal of Cancer|October 28, 2015
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancerS H Lim, T W Kim, Y S Hong, et al.
Pageof 23